Abstract
Originating from Wuhan, China, COVID-19 has rapidly spread worldwide. Neurological manifestations are more commonly associated with severe COVID-19 infection. Guillain-Barré syndrome (GBS) is a rare immune-mediated postinfectious neuropathy. It has been reported as a possible rare complication of COVID-19. We report a case of GBS associated with COVID-19 in the UK.
Keywords:
infectious diseases; neurology; peripheral nerve disease.
© BMJ Publishing Group Limited 2020. No commercial re-use. See rights and permissions. Published by BMJ.
MeSH terms
-
Betacoronavirus* / isolation & purification
-
Betacoronavirus* / pathogenicity
-
COVID-19
-
Coronavirus Infections* / complications
-
Coronavirus Infections* / diagnosis
-
Coronavirus Infections* / physiopathology
-
Diagnostic Techniques, Neurological
-
Guillain-Barre Syndrome* / diagnosis
-
Guillain-Barre Syndrome* / etiology
-
Guillain-Barre Syndrome* / physiopathology
-
Guillain-Barre Syndrome* / therapy
-
Humans
-
Immunoglobulins, Intravenous / administration & dosage*
-
Immunologic Factors / administration & dosage
-
Intubation, Gastrointestinal / methods
-
Lower Extremity* / innervation
-
Lower Extremity* / physiopathology
-
Male
-
Middle Aged
-
Neuralgia / etiology
-
Neuralgia / therapy
-
Neurologic Examination / methods
-
Neurological Rehabilitation
-
Pandemics*
-
Pneumonia, Viral* / complications
-
Pneumonia, Viral* / diagnosis
-
Pneumonia, Viral* / physiopathology
-
SARS-CoV-2
-
Treatment Outcome
Substances
-
Immunoglobulins, Intravenous
-
Immunologic Factors